Your browser doesn't support javascript.
loading
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.
Nielsen, Wils; Strand, Vibeke; Simon, Lee S; Parodis, Ioannis; Kim, Alfred H J; Desai, Maya; Enman, Yvonne; Wallace, Daniel; Chaichian, Yashaar; Navarra, Sandra; Aranow, Cynthia; MacKay, Meggan; Trotter, Kimberly; Tayer-Shifman, Oshrat E; Duarte-Garcia, Ali; Shan Tam, Lai; Ugarte-Gil, Manuel F; PonsEstel, Guillermo J; Reynolds, John A; Nikpour, Mandana; Hoi, Alberta; Romero-Diaz, Juanita; Papachristos, Danaë; Aggarwal, Amita; Mok, Chi Chiu; Fujio, Keishi; Ramsey-Goldman, Rosalind; Howe, Aaron; Kia, Behdin Nowrouzi; Bonilla, Dennisse; Thumboo, Julian; Mosca, Marta; Aringer, Martin; Johnson, Sindhu R; Drucker, Aaron M; Morand, Eric; Bruce, Ian; Touma, Zahi.
Afiliação
  • Nielsen W; University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada.
  • Strand V; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA.
  • Simon LS; SDG, LLC, Cambridge, Massachusetts, USA.
  • Parodis I; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden; Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, S
  • Kim AHJ; Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Desai M; Faculty of Design, OCAD University, Toronto, Ontario, Canada.
  • Enman Y; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;; Swedish Rheumatism Association, Stockholm, Sweden.
  • Wallace D; Division of Rheumatology, Department of Medicine, Cedars-Sinai; David Geffen School of Medicine at UCLA, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Chaichian Y; Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Navarra S; Department of Rheumatology, University of Santo Tomas Hospital, Manila, Philippines.
  • Aranow C; Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
  • MacKay M; Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
  • Trotter K; Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois, USA.
  • Tayer-Shifman OE; Rheumatology Unit, Meir Medical Center, Kfar Saba, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Duarte-Garcia A; Division of Rheumatology, Mayo Clinic, Rochester, MN.
  • Shan Tam L; Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
  • Ugarte-Gil MF; Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas. Universidad Cientifica del Sur, Lima, Peru; Rheumatology Department. Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.
  • PonsEstel GJ; Grupo Oroño - Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
  • Reynolds JA; Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, 1724University of Birmingham, Birmingham, UK.
  • Nikpour M; The University of Sydney School of Public Health, Camperdown, NSW, 2006, Australia.
  • Hoi A; Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Melbourne, Australia.
  • Romero-Diaz J; Instituto Nacional de Ciencias Médicas y Nutricion, México City, México.
  • Papachristos D; Department of Rheumatology, Mater Hospital, Brisbane, Australia.
  • Aggarwal A; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India.
  • Mok CC; Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, China.
  • Fujio K; Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
  • Ramsey-Goldman R; Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Howe A; Restore Lab, Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, ON M5G 1V7, Canada.
  • Kia BN; Restore Lab, Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, ON M5G 1V7, Canada.
  • Bonilla D; University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada.
  • Thumboo J; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore.
  • Mosca M; Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Aringer M; Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine TU Dresden, Dresden, Germany.
  • Johnson SR; Toronto Western Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada.
  • Drucker AM; Division of Dermatology, Department of Medicine, University of Toronto and Women's College Hospital.
  • Morand E; Centre for Inflammatory Disease, Monash University, Melbourne, Australia.
  • Bruce I; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.
  • Touma Z; University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada. Electronic address: zahi.touma@uhn.ca.
Semin Arthritis Rheum ; 65: 152380, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38281467
ABSTRACT

BACKGROUND:

The Outcome Measures in Rheumatology (OMERACT) Systemic Lupus Erythematosus (SLE) Working Group held a Special Interest Group (SIG) at the OMERACT 2023 conference in Colorado Springs where SLE collaborators reviewed domain sub-themes generated through qualitative research and literature review.

OBJECTIVE:

The objective of the SIG and the subsequent meetings of the SLE Working Group was to begin the winnowing and binning of candidate domain sub-themes into a preliminary list of candidate domains that will proceed to the consensus Delphi exercise for the SLE COS.

METHODS:

Four breakout groups at the SLE SIG in Colorado Springs winnowed and binned 132 domain sub-themes into candidate domains, which was continued with a series of virtual meetings by an advisory group of SLE patient research partners (PRPs), members of the OMERACT SLE Working Group Steering Committee, and other collaborators.

RESULTS:

The 132 domain sub-themes were reduced to a preliminary list of 20 candidate domains based on their clinical and research relevance for clinical trials and research studies.

CONCLUSION:

A meaningful and substantial winnowing and binning of candidate domains for the SLE COS was achieved resulting in a preliminary list of 20 candidate domains.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reumatologia / Lúpus Eritematoso Sistêmico Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Revista: Semin Arthritis Rheum Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reumatologia / Lúpus Eritematoso Sistêmico Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Revista: Semin Arthritis Rheum Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá